Unknown

Dataset Information

Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.


ABSTRACT:

Objective

To examine the safety and effectiveness of antidepressant versus mood stabilizer monotherapy in rapid versus non-rapid cycling bipolar II disorder.

Method

Subjects ≥18 years old with bipolar II depression (n = 129) were randomized to double-blind venlafaxine or lithium carbonate monotherapy for 12 weeks. Responders (n = 59) received continuation monotherapy for six additional months.

Results

Rapid cycling did not affect frequency of response or change over time in depressive symptoms. Rapid cycling status did not affect frequency of depressive relapse or sustained treatment response. Rapid cyclers were more likely to experience hypomanic symptoms (P = 0.005) during continuation monotherapy; however, rates were similar in venlafaxine (17.6%) and lithium (42.9

SUBMITTER: Lorenzo-Luaces L 

PROVIDER: S-EPMC4879786 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature